Abrams G W, Azen S P, McCuen B W, Flynn H W, Lai M Y, Ryan S J
Kresge Eye Institute, Wayne State University, Detroit, Mich, USA.
Arch Ophthalmol. 1997 Mar;115(3):335-44. doi: 10.1001/archopht.1997.01100150337005.
The Silicone Study evaluated the outcomes of vitreoretinal surgery for retinal detachment with proliferative vitreoretinopathy (PVR).
To evaluate short-term (up to 36 months) outcomes in eyes randomized to silicone oil or perfluoropropane gas and long-term (up to 72 months) outcomes in eyes with attached maculas at 36 months.
Prospective, randomized, multicentered surgical trial.
Community- and university-based vitreoretinal practices.
Two-hundred sixty-five eyes with PVR randomized to perfluoropropane gas and silicone oil with follow-up through 3 years (cohort 1) and 249 eyes with attached maculas at 36 months (121 eyes randomized to long-acting gas [either sulfur hexafluoride or perfluoropropane] and 128 eyes randomized to silicone oil) with follow-up up to 6 years (cohort 2). Both cohorts consisted of eyes that had and had not undergone vitrectomy for PVR (groups 1 and 2, respectively) before randomization. Of the 265 eyes in cohort 1, 24-month follow-up data were available for 218 eyes (82%) and 36-month follow-up data were available for 196 eyes (74%). Of 208 eyes in cohort 2, 48-month follow-up data were available for 146 eyes (70%), 60-month follow-up data for 119 eyes (57%), and 72-month follow-up data for 73 eyes (35%).
Vitrectomy surgery for PVR with a long-acting gas or silicone oil as the intraocular tamponade.
Changes in visual acuity, recurrent retinal detachment, and incidence of complications.
In group 1 of cohort 1, compared with oil-treated eyes, gas-treated eyes had a higher rate of complete retinal reattachment from 18 to 36 months (P < .05). No other differences were found. In group 2 of cohort 1, no notable differences were found between treatment arms. In cohort 2, during 6 years of follow-up, attachment of the macula was maintained for all eyes. No notable differences in the rates of complete retinal attachment, visual acuity of 5/200 or better, or glaucoma were found between treatment groups. In contrast, gas-treated eyes had more hypotony (P < .001). Silicone oil-treated eyes that underwent subsequent surgery were more likely to have the oil retained (P = .02). Compared with oil-retained eyes, oil-removed eyes had higher rates of complete posterior attachment (P = .01) and of a visual acuity of 5/200 or better (P < .001) and less keratopathy (P < .05). Compared with oil-removed eyes, gas-treated eyes had a worse visual acuity outcome (P < .05) and more hypotony (P < .01).
The Silicone Study showed that silicone oil and perfluoropropane gas were equal in most respects for the management of retinal detachments with PVR. Success in the first surgery for PVR is paramount for obtaining better visual results. Overall, surgery for PVR had a high likelihood of retinal reattachment, and if anatomically and visually successful at 3 years, there is an excellent chance that the results will be maintained over the long-term.
硅油研究评估了玻璃体视网膜手术治疗伴有增殖性玻璃体视网膜病变(PVR)的视网膜脱离的疗效。
评估随机接受硅油或全氟丙烷气体治疗的眼睛的短期(最长36个月)疗效,以及在36个月时黄斑已复位的眼睛的长期(最长72个月)疗效。
前瞻性、随机、多中心手术试验。
社区和大学的玻璃体视网膜诊疗机构。
265只患有PVR的眼睛被随机分为接受全氟丙烷气体和硅油治疗,并随访3年(队列1);249只在36个月时黄斑已复位的眼睛(121只被随机分为接受长效气体[六氟化硫或全氟丙烷]治疗,128只被随机分为接受硅油治疗),随访长达6年(队列2)。两个队列均包括在随机分组前已接受和未接受PVR玻璃体切除术的眼睛(分别为组1和组2)。在队列1的265只眼睛中,218只眼睛(82%)有24个月的随访数据,196只眼睛(74%)有36个月的随访数据。在队列2的208只眼睛中,146只眼睛(70%)有48个月的随访数据,119只眼睛(57%)有60个月的随访数据,73只眼睛(35%)有72个月的随访数据。
采用长效气体或硅油作为眼内填充物进行PVR玻璃体切除术。
视力变化、视网膜脱离复发情况及并发症发生率。
在队列1的组1中,与接受硅油治疗的眼睛相比,接受气体治疗的眼睛在18至36个月时完全视网膜复位率更高(P < 0.05)。未发现其他差异。在队列1的组2中,各治疗组之间未发现明显差异。在队列2中,在6年的随访期间,所有眼睛的黄斑均保持复位。治疗组之间在完全视网膜附着率、视力达到5/200或更好的比例或青光眼发生率方面未发现明显差异。相比之下,接受气体治疗的眼睛低眼压情况更多(P < 0.001)。接受硅油治疗且随后接受手术的眼睛更有可能保留硅油(P = 0.02)。与保留硅油的眼睛相比,取出硅油的眼睛完全后极部附着率更高(P = 0.01)、视力达到5/200或更好的比例更高(P < 0.001)且角膜病变更少(P < 0.05)。与取出硅油的眼睛相比,接受气体治疗的眼睛视力结果更差(P < 0.05)且低眼压情况更多(P < 0.01)。
硅油研究表明,在治疗伴有PVR的视网膜脱离方面,硅油和全氟丙烷气体在大多数方面效果相当。PVR首次手术的成功对于获得更好的视觉效果至关重要。总体而言,PVR手术视网膜复位的可能性很高,如果在3年时解剖和视觉上成功,那么长期维持效果的机会很大。